Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation

by Tunn UW, Gruca D, Bacher P
Published 2013-04-01

Integrating diet and exercise into care of prostate cancer patients on androgen deprivation therapy

by Moyad MA, Newton RU, Tunn UW, Gruca D
Published 2016-08-01

Intramuscular depot formulations of leuprolide acetate suppress testosterone levels below a 20 ng/dL threshold: a retrospective analysis of two Phase III studies

by Spitz A, Gittelman M, Karsh LI, Dragnic S, Soliman AM, Lele A, Gruca D, Norton M
Published 2016-08-01